NSE: ORTINLAB - Ortin Laboratories Limited

半年間の収益性: +15.94%
配当利回り: 0.00%

プロモーションスケジュール Ortin Laboratories Limited

ja.porti.ru30.0030.0027.0027.0024.0024.0021.0021.0018.0018.0015.0015.005月 '235月 '236月 '236月 '237月 '237月 '238月 '238月 '239月 '239月 '2310月 '2310月 '2311月 '2311月 '2312月 '2312月 '23202420242月 '242月 '243月 '243月 '244月 '244月 '245月 '245月 '246月 '246月 '247月 '247月 '248月 '248月 '249月 '249月 '2410月 '2410月 '24
SVGダウンロード
PNGダウンロード
CSVダウンロード

会社について Ortin Laboratories Limited

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products.

さらに詳しく
Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

ISIN INE749B01020
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Сайт https://www.ortinlabsindia.com
Цена ао 20.87
1日あたりの価格変動: 0% (20.87)
週ごとの価格変動: -1.32% (21.15)
月ごとの料金変更: -2.75% (21.46)
3ヶ月間の価格変動: +5.24% (19.83)
半年間の価格変動: +15.94% (18)
年間の価格変動: +5.67% (19.75)
3年間の価格推移: -40.54% (35.1)
5年間の価格推移: +206.41% (6.8112)
年初からの価格変動: +17.58% (17.75)

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -96.31 0
収益性 Ebitda, % -91.11 0
収益性 EPS, % 0 0
合計: 0

スーパーバイザー 役職 支払い 生年
Mr. Sanka Murali Krishna Murthy CEO & MD 1959 (66 年)
Mr. Sanka Srinivasa Kumar CFO & Whole Time Director 1965 (60 年)

住所: India, Hyderabad, D. No. 1-8-B4 F3 HIG - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.ortinlabsindia.com